These findings suggest that suppressed expression of the TBX2 subfamily likely occurs very early on in NSCLC pathogenesis and may serve as a viable biomarker for early detection of lung cancer among suspect smokers with indeterminate nodules. The gene discussed is TBX2; the disease is lung carcinoma.